1. J.L. Junien, M. Guillaume, C. Lakatos andJ. Sterne,Bronchodilator and antiallergic properties of LA 2851 (2-4-diamino-7-methyl-pyrazolo (1,5-a) 1,3,5-triazine), Arch. Int. Pharmacodyn. Ther.252, 313–326 (1981).
2. K.F. Austen andR.P. Orange,Bronchial asthma: The possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease, Am. Rev. Resp. Dis.112, 423–436 (1975).
3. R.E.C. Altounyan, Review of the clinical activity and modes of action of sodium cromoglycate. In:The Mast Cell, pp. 199–216. (EdsJ. Pepys andA.M. Edwards). Pitman, London 1979.
4. M. Plaut andL.M. Lichenstein, Cellular and chemical bais of the allergic inflammatory responses: Component parts and control mechanisms. In:Allergy, Principles and Practice, pp. 155–176. (EdsE. Middleton, C.E. Reed andE.F. Ellis). Mosby Company 1978.
5. P.F. Kohler, Immune complexes and allergic Disease. In:Allergy, Principles and Practice, pp. 115–138. (EdsE. Middleton, C.E. Reed andE.F. Ellis). Mosby Company 1978.